78 related articles for article (PubMed ID: 21528214)
1. Proliferation markers and cell cycle associated expression of prosomes in breast cancers of Parsis and non-Parsis.
Bhui A; Bureau J; Parikh V; Kukreti R; Scherrer K; Mondal A; Therwath A
Int J Oncol; 1997 Aug; 11(2):297-304. PubMed ID: 21528214
[TBL] [Abstract][Full Text] [Related]
2. Novel cellular markers in breast cancer.
Bhui A; Bureau J; Abbas A; Mondal A; Scherrer K; Kurkure A; Therwath A
Int J Oncol; 1996 Oct; 9(4):669-77. PubMed ID: 21541567
[TBL] [Abstract][Full Text] [Related]
3. Increased prosomal proteins in breast cancer cells and in neighboring normal cells in Parsi and non-Parsi populations.
Bhui-Kaur A; Therwath A; Henry L; Chiesa J; Kurkure A; Scherrer K; Bureau JP
J Cancer Res Clin Oncol; 1998; 124(2):117-26. PubMed ID: 9654195
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell surface glycoprotein CD44 and integrins in breast cancers among Indian women.
Menon MM; Thakur R; Simha MR; Kurkure AP; Kenkare UW; Doctor VM
Tumori; 1998; 84(5):589-94. PubMed ID: 9862522
[TBL] [Abstract][Full Text] [Related]
5. p53 alterations in breast cancer of the Parsi ethnic group.
Abbas A; Kukreti R; Naik S; Therwath A
Int J Oncol; 1997 Feb; 10(2):401-4. PubMed ID: 21533391
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
[TBL] [Abstract][Full Text] [Related]
8. "Like sugar in milk": reconstructing the genetic history of the Parsi population.
Chaubey G; Ayub Q; Rai N; Prakash S; Mushrif-Tripathy V; Mezzavilla M; Pathak AK; Tamang R; Firasat S; Reidla M; Karmin M; Rani DS; Reddy AG; Parik J; Metspalu E; Rootsi S; Dalal K; Khaliq S; Mehdi SQ; Singh L; Metspalu M; Kivisild T; Tyler-Smith C; Villems R; Thangaraj K
Genome Biol; 2017 Jun; 18(1):110. PubMed ID: 28615043
[TBL] [Abstract][Full Text] [Related]
9. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
van Dierendonck JH; Wijsman JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Am J Pathol; 1991 May; 138(5):1165-72. PubMed ID: 1673821
[TBL] [Abstract][Full Text] [Related]
11. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
Keshgegian AA; Cnaan A
Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
[TBL] [Abstract][Full Text] [Related]
12. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological features and prognosis of breast cancer in different religious communities in India.
Badwe RA; Gangawal S; Mittra I; Desai PB
Indian J Cancer; 1990 Dec; 27(4):220-8. PubMed ID: 2090578
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
18. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens.
Ma CK; De Peralta MN; Amin MB; Linden MD; Dekovich AA; Kubus JJ; Zarbo RJ
Am J Clin Pathol; 1997 Dec; 108(6):641-51. PubMed ID: 9384445
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer and religion in greater Bombay women: an epidemiological study of 2130 women over a 9-year period.
Jussawalla DJ; Jain DK
Br J Cancer; 1977 Nov; 36(5):634-8. PubMed ID: 597382
[TBL] [Abstract][Full Text] [Related]
20. [Distinction between benign and malignant pheochromocytomas].
Liu TH; Chen YJ; Wu SF; Gao J; Jiang WJ; Lu ZH; Guan J; Wei SZ; Luo YF; Cao JL; Wan JW
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):198-202. PubMed ID: 15256107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
